Nephros, Inc. Receives the 2009 Frost & Sullivan Medical Device Patient Care Company of the ...(in blood purification mid-dilution HDF w...),Health

Date:1/14/2009

in blood purification, mid-dilution HDF with the OLpur(TM) MD hemodiafilters combines the higher filtration rate of pre-dilution HDF with the small molecule clearance of post-dilution HDF. The filtration of critical uremic toxins has several beneficial outcomes, such as improving patient survival, reducing medication requirements, and improving blood pressure control.

Nephros's current MDHDF product line consists of two different filters: the MD 190 and the MD 220. Both products are focused on Nephros's proprietary technology and establish a reputation with a platform instead of a product.

"In patient care settings, the initial flux characteristic of revolutionary technologies will eventually give way to acceptance and adoption in light of exceptional performance," adds Rajan of Frost & Sullivan. "Hemodiafiltration is poised to become a breakthrough platform in the area of dialysis."

"We are honored to receive this prestigious award from Frost and Sullivan," explains Ernest Elgin, President and CEO of Nephros, Inc., "and be recognized for leadership and innovation in improving patient care within the medical device industry as well as exploiting the potential of promising technologies."

Nephros' products are marketed and sold outside of the U.S. and have displayed rapid revenue growth. In 2008, third quarter sales showed an increase of 251 percent in comparison with sales in 2007. Overall company revenue has increased by 22 percent nine months into 2008, compared with that of 2007. Through the reduction of overhead costs and operational expenditures, Nephros has focused solely upon maximizing its value to shareholders. The company has also taken further steps such as relocation of its headquarters and the restructuring of its management to improve its strategic position.

The Frost & Sullivan Award for Company of the Year is presented each year to the company that h
'/>"/>

SOURCE Nephros, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. Med-Emerg International Inc. receives court approval for AIM Health Group arrangement
2. St. Marys Health System in Maine Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service
3. Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements
4. Dalcons Healthcare Communications Software Receives Internet Telephony Magazine Product of the Year Award
5. Nemours Center for Childhood Cancer Research Receives Over $1 Million in Grants for Cancer Research in 2008
6. WellPoint Receives Seven eHealthcare Leadership Awards
7. Ziosoft Receives FDA Clearance for CT Brain Perfusion Application
8. Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals
9. Guru Program Pioneered by Tom Gable Receives Official Registration from USPTO
10. Accuray Receives Prestigious Awards for 2008 Advertising Campaign
11. AGA Medical Receives Japanese Approval for AMPLATZER(R) Duct Occluder